Is ICD-programming on double intraoperative defibrillation-threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (low energy endotak trial - LEET);Ist eine ICD-programmierung auf eine schockenergie der doppelten intraoperativen defibrillationsschwelle im langzeitverlauf sicher effektiv? Ergebnisse einer prospektiven randomisierten multizenterstudie (low energy endotak trial - LEET)

Zeitschrift fur Kardiologie

Volumn 88, Issue 2, 1999, Pages 103-112

  Himmrich, E ^a   Liebrich, A ^a   Michel, U ^b   Neuzner, J ^c   Pitschner, H ^c   Heisel, A ^d   Vester, E ^e   Ganschov, U ^e   Jung, J ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b CPI/Guidant   (Belgium)

^c KERCKHOFF HEART CENTER   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Defibrillation threshold; Efficacy; Energy safety margin; Implantable cardioverter defibrillator

Indexed keywords

ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; ELECTROSTIMULATION THERAPY; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; SAFETY; SUDDEN DEATH; TREATMENT OUTCOME;

DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT SAFETY; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0033060094     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050266     Document Type: Article

References (34)

1. Akahar M, Jazayeri M, Sra J, Tehou P, Rovang K, Blank Z, Dhala A, Deshpande S, Axtell K (1993) Implantable cardioverter/defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation. PACE 16:511-518
2. Bardy GH, Hofer B, Johnson G, Kudenschuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D (1993) Implantable transvenous cardioverter-defibrillators. Circulation 87:1152-1168
3. Block M, Hammel D, Böcker D, Breithard G et al (1994) Transvenous-sucutaneous defibrillation leads; effect of transvenous electrode polarity on defibrillation threshold. J of Cardiovascular Elektrophysiology 5:912-918
4. Böckler D, Block M, Isbuch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G (1993) Do patients with an implantable defibrillator live longer? J Am Coll Card 21:1638-1644
5. Brooks R, Garan H, Torchine D, Vlahakes GJ, Dziuban S, Newell J, Mc Govern BA, Ruskin N (1994) Three-year outcome of a nonthoracotomy approach to cardioverter/defibrillator implantation in 189 consecutive patients. Am J of Cardiol 74: 1011-1015
6. Brunn J, Block M, Weber M, Breithardt et al (1997) Ergebnisse der Testung der Defibrillationsfunktion implantierbarer Kardioverter/Defibrillator. Z. Kardiologie 86: 450-459
7. Davy JM, Fain ES, Dorian P, Winkle RA (1987) The relationship between successful defibrillation and delivered energy in open-chest dogs; reappriasal of the defibrillation threshold concept. Am Heart J. 113:77-84
8. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ and the high defibrillation threshold investigators (1992) Clinical characteristics and outcome of patients with high defibrillation threshold Circulation 86:1206-1216
9. Frommer M, Brachman J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, Den Dulk K, Coumel P, Camm AJ, Touboul P (1992) Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator; results of a European multicenter study of 102 patients. Circulation 86:363-374
10. Guarnieri T, Levine JH, Veltri EP (1987) Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 60:1061
11. Habermann RJ, Veltri EP, Mover MM (1988) The effect of amiodarone on defibrillation threshold. J. of Cardiovascular Electrophysiology 2:415
12. Hsia HM, Mitra RI, Flores BT, Marchlinski (1994) Early postoperative increase in defibrillation threshold with non thoracotomy systems in humans. PACE 17:1166-1173
13. Jones DL, Klein GJ, Giuraudon GM, Sharma AD, Yee R, Kallok MJ (1988) Prediction of defibrillation threshold measurement with sequential pulses and two current pathways in humans. Circulation 78:1144-1149
14. Jung W (1995) Der implantierbare Kardioverter-Defibrillator. Steinkopff, Darmstadt, S 39-53
15. Kopp DE, Kall JG, Kinder C, Glaschock D, Wilber D (1995) Effect of Amiodarone and left ventricular mass on defibrillation energy requirements; monophasic vs hiphasic shock. PACE 18:872
16. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC (1988) Relation of the intraoperative defibrillation threshold to successful prospective defibrillation with an automatic implantable cardioverter/defibrillator. Am J Cardiol 62:393-398
17. Martin DT, John R, Ventitti FJ (1995) Increase in defibrillation threshold in non thoracotomy implantable defibrillators using a biphasic waveform. Am J Cardiol 76:263-266
18. Minten J, Cuypers A, Binsbergen E, Lindemans F (1995) Medtronic Model 7219 Jewel PCD, European Clinical Report. Bakken Research Center BV: Medtronic, January 1995
19. Mirowski M, Reid P, Mower NM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New England Journal Med. 303:322-324
20. Neuzner J, Pitchner HF, Stöhring R, Reinisch P, Schlepper M (1995) Implantierbare Kardioverter/Defibrillator mit endokardialen Elektrodensystemen: Langfristige Stabilität der Defibrillations-effektivität. Z Kardiol 84:44-50
21. Nisam S, Kaye SA, Mover MH, Hull M (1995) AICD automatic cardioverter/defibrillator clinical update: 14 years experience in over 34000 patients. PACE 16:142-147
22. Perings Ch, Winter J, Kuhls S, Neuzner J (1995) The chronic defibrillation threshold after implantation of single lead system: Long term follow-up in 32 patients. PACE 18:361
23. Pinski SL, Mick MJ, Arnold AZ, Golding L, McCarthy PM, Castle LW, Maloney JD, Trohman RG (1991) Retrospective analysis of patients undergoing one-or-two-stage strategies for myocardial revascularisation and implantable cardioverter defibrillator implantation. PACE 14:1138-1147
24. Poole JE, Bardy GH, Dolack GL, Kudenschuk PJ, Andersond J, Johnson G (1995) Serial defibrillation threshold measure in man: a prospective controlled study. Journal of Cardiovascular Electrophysiology 6:19-25
25. Saksena S, An H, Mehra R, De Groot P, Krol RB, Burkhardt E, John T (1992) Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillator using endocardial leads. Am J of Cardiol 70:304-310
26. Siebels J, Schneider MAE, Kuck K-H (1993) Niederenergetische Kardioversions-Defibrillationsgeräte zur Behandlung von ventrikulaΣren Tachykardien und Kammerflimmern. Z. Kardiol., 82:683-691
27. Singer I, Lang D (1992) Defibrillation threshold: clinical utility and therapeutic implication. PACE 15:932-949
28. The PCD Investigator Group: (1994) Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. Am Coll Cardiol 23:1521-1530
29. Venditti FJ, Martin DT, Vassolas G, Bowen S (1994) Rise in chronic defibrillation threshold in nonthoracotomy implantable defibrillator. Circulation 89:216-223
30. Vester EG, Ganschov US, O'Connor SA, (1995) Analysis of first shock failure in a mulitfunctional implantable antitachycardy system. Lessons from the PRX II-Study. PACE 18:363
31. Vester EG (1997) Differentialdiagnostik und Therapie ventrikulärer Tachyarrhythmien Steinkopff, Darmstadt, pp 162-164
32. Wever EFD, Hauer RNW, Crijns HJGM, Van Capelle FJL, Bakker PFA, Robles de Medina EO (1994) Dutch prospective randomized trial of implantable defibrillator as first-choice therapy versus conventional strategy. PACE 17:760-771
33. Winkle RA, Mead RH, Ruber MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T (1983) The relationship between lower defibrillation threshold and increased implant success rate for the TRIAD lead system. PACE 20 (4):1206
34. Winter J, Vester EG, Kuhls S, Kantartzis M, Perings Ch, Pauschinger M, Strauer BE, Birks W (1993) Defibrillation energy requirements with single endocardial (Endotak) lead. PACE 16, Part II:540-546